| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |